PATENTLY ABSURD
AFTER all the laurels and accolades for developing a new-generation vaccine against COVID-19 at the height of the pandemic, the two competing companies that developed the mRNA jabs are facing off in a critical patent dispute. The outcome of the big-ticket litigation will determine how accessible the mRNA technology will be in developing future vaccines and therapies against a host of health hazards, ranging from influenza to cancer.
It took the industry by surprise when after a year of doing business peaceably and earning billions of dollars each, Moderna filed a patent infringement suit against its rival, PfizerBioNTech on August 26. BioNTech and Moderna had both developed their COVID-19 vaccines using the mRNA platform to attack the SARS-CoV-2 virus. While BioNTech, a biotechnology startup in Germany, tied up with multinational Pfizer for quick development of the Comirnaty vaccine, Moderna chose to go it alone to make its Spikevax vaccine.
Now, Moderna claims Pfizer-BioNTech has infringed three patents on its vaccine delivery system, which gets the drug inside a recipient's cells and generates a protein. In lawsuits filed in the US District Court for the District of Massachusetts and the Higher Regional Court of Düsseldorf, where BioNTech is based, Moderna says that Comirnaty infringes patents it had filed between 2010 and 2016 covering the company's "foundational mRNA technology". It accuses its competitor of copying "this groundbreaking technology" which was critical to the development of its own Spikevax.
This story is from the September 16, 2022 edition of Down To Earth.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the September 16, 2022 edition of Down To Earth.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
International Women's Day Special SHE
In India, women self-help groups have been a source of empowerment, fostering economic independence, social stature and community resilience.
MODERATELY YOURS
The crunchy, slightly sweet tubers of shankhalu can be a healthy addition to one's diet
TROUBLED TEAK
Farmers need to be sensitised about right planting materials and cultivation techniques to benefit from high-value teak plantations
Follow the Chinese way on high tech
Making universities the hub of innovation and churning out scientists adept in frontier technology has put China at the top
Stronger resolve
In the face of climate change, countries make a slew of commitments to ensure conservation of migratory species
MIND YOUR THOUGHTS
Technologies with potential to read one’s thoughts have grown tremendously in recent years driven largely by artificial intelligence, a develooment that raises ethical and privacy issues
Winter Without Snow
Record-low snowfall in the Himalayas is evidence that climate change is speeding up
UNDERRATED GREEN
Kohlrabi is a healthy but little used member of the cabbage family
Historical hindsight
An encyclopaedic work capturing the breathless changes in Assam’s recent history as well as its struggle for identity and modernity
Making jugaad a global success
Frugal innovation is the new concept that companies are adopting to take technology to developing countries